Hence, the present study was designed to investigate the possible modifying effect of GSTs polymorphisms (GSTM1, GSTT1, GSTP1, GSTO1 and GSTO2) in the susceptibility to T2DM and diabetic nephropathy as its major microvascular complication. This evidence concerns the gene GSTO1 and diabetic kidney disease.